A Japanese pharmaceutical company focused on the research, development, and commercialization of prescription medicines, with a growing emphasis on oncology. Its pipeline includes antibody-drug conjugate cancer therapies developed internally and through partnerships, including collaborations with gl...
1 member of Congress has disclosed 1 trade in Daiichi Sankyo Co Ltd (DSKY), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2016-02-03 | MICHAEL T. MCCAUL | sell | $1K – $15K |